Philippine Council for Health Research and Development

Browse over 80 requests from this government agency

Go Back
  • REQUEST SUBMITTED

    You have submitted an FOI request

    Date: 2022-08-10 08:52:35.853732

  • PROCESSING REQUEST

    Your request is already in review

  • REQUEST REFERRED

    Your request was referred

    Date: 2022-08-11 17:01:16.663046

  • 4

    RATE YOUR REQUEST

    How was your request?

PCHRD research papers

Requested from PCHRD by M. Cadaba at 08:52 AM on Aug 10, 2022.
Purpose: For Research and Development purposes
Date of Coverage: 01/01/1990 - 12/19/1994
Tracking no: #PCHRD-713148514245

Cadaba 08:52 AM, Aug 10, 2022

Vergara RM, Narciso P, Bardilosa JG. Efficacy of Sambong Tablet in Filipino Patients with Distal 3rd Ureterolithiasis. UERMMMC. 1994. Unpublished.

3.	De Leon D, Cortes-Maramba N. Blumea balsamifera L. (Sambong) for the treatment of Urinary Tract Stone: A Randomized placebo controlled study Phase III Clinical Trial. Published in the Technology Transfer Document by NIRPROMP and the Philippine Council for Health Research and Development. 1990

6. 6.	NIRPROMP. Blumea balsamifera L. (Sambong) for the treatment of Urinary Tract Stones: A randomized placebo controlled study Phase III Clinical Tri

05:01 PM, Aug 11, 2022

August 10, 2022
 

Dear Ms. Maricris Cadaba,

Thank you for your request dated August 10, 2022, under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch on the following researches:

Efficacy of Sambong Tablet in Filipino Patients with Distal 3rd Ureterolithiasis 

Blumea  balsamifera L. (Sambong) for the treatment of Urinary Tract Stone: A Randomized placebo controlled study Phase III Clinical Trial

NIRPROMP. Blumea balsamifera L. (Sambong) for the treatment of Urinary Tract Stones: A randomized placebo controlled study Phase III Clinical Trial

The Philippine Council for Health Research and Development (PCHRD), one of the sectoral councils of the Department of Science and Technology (DOST), is mandated to: (1) formulate policies, plans, programs, project, and strategies for health S&T development; (2) program and allocate government and external funds for research and development (R&D); (3) monitor R&D projects; and (4) generate external funds.
 
While our aim is to provide information whenever possible, we regret that our office does not have the information you have requested. However, we referred your request to the University of the Philippines (UP) Manila to assist you with your concern. 

You may also directly coordinate with the following institutions at:

UP Manila College of Medicine
Email address: upcm.upmanila@up.edu.ph
Telephone number: (632) 8536-1392

UP Manila College of Pharmacology
Telephone number: (632) 8526-4170

University of the East Ramon Magsaysay Memorial Medical Center, Inc.  
Telephone number: (632) 8715-0861

For related studies, you may also visit HERDIN PLUS at http://herdin.ph. 

Should you have further queries, kindly contact us using the reply function on the eFOI portal at https://www.foi.gov.ph/requests/aglzfmVmb2ktcGhyHwsSB0NvbnRlbnQiElBDSFJELTcxMzE0ODUxNDI0NQw, with ticket number #PCHRD-713148514245.
 
Respectfully yours,

Alec Gonzales
DOST-PCHRD FOI Receiving Officer

Is this request offensive?

Requests for personal information and vexatious requests are not considered valid requests for Official Information.

If you believe this request is not suitable, you can report it for attention by the site administrators.